Violation Tracker Parent Company Summary
Parent Company Name:
Pfizer
Ownership Structure:
publicly traded (ticker symbol PFE)
Headquartered in:
New York
Major Industry:
pharmaceuticals
Specific Industry:
pharmaceuticals
Penalty total since 2000:
$4,747,652,947
Number of records:
80
Top 5 Offense Groups (Groups Defined) |
Penalty Total |
Number of Records |
healthcare-related offenses |
$3,373,675,000 |
10 |
government-contracting-related offenses |
$1,161,001,892 |
23 |
safety-related offenses |
$104,004,655 |
10 |
competition-related offenses |
$98,166,568 |
8 |
environment-related offenses |
$5,324,642 |
23 |
Top 5 Primary Offense Types |
Penalty Total |
Number of Records |
off-label or unapproved promotion of medical products |
$3,373,675,000 |
10 |
False Claims Act and related |
$1,161,001,892 |
23 |
drug or medical equipment safety violation |
$103,840,000 |
5 |
Foreign Corrupt Practices Act |
$60,216,568 |
3 |
kickbacks and bribery |
$34,700,000 |
3 |
Notes:
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Associated Names:
Alpharma USPD, Inc. and Purepac Pharmaceutical Co.; Alpharma USPD, Inc.,; HOSPIRA; KING PHARMACEUTICALS LLC; PFIZER; PFIZER / GROTON; PFIZER GLOBAL MANUFACTURING 090110003800129; PFIZER GLOBAL MANUFACTURING 090110003800170; PFIZER GLOBAL MFG; PFIZER HCP; PFIZER PHARMACEUTICAL(WARNER LAMBERT) 721450001000059; Pfizer, Inc. and Pharmacia Corporation; PHARMACIA; PHARMACIA AND UPJOHN CARIBE; Pharmacia Corporation; Purepac Pharmaceutical Co.; Purepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC; S […]
Links:
For an overview of this company’s accountability track record, read its Corporate Rap Sheet here.
For more details on misconduct by this company, see its entry in the Project On Government Oversight’s Federal Contractor Misconduct Database.
For a summary of this company’s federal contracts, see its page on Fedspending.
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.
https://violationtracker.goodjobsfirst.org/parent/pfizer